REVIEW
Accepted on 20 Oct 2025
Clinical Application and Drug Resistance Mechanism of Gemcitabine
doi 10.3389/fcell.2025.1702720
- Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Research Topics
- Advancements in Solid Tumor Immunotherapy: Enhancing Efficacy and Overcoming Resistance
Advancements in Solid Tumor Immunotherapy: Enhancing Efficacy and Overcoming Resistance
2,686
Total downloads
13k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Accepted on 22 Sep 2025
Microtubule Regulation in Cancer Cells
doi 10.3389/fcell.2025.1677302
- 241 views
ORIGINAL RESEARCH
Published on 22 Sep 2025
Nomogram for predicting pathological complete response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer
doi 10.3389/fcell.2025.1679782
- 656 views
REVIEW
Published on 15 Aug 2025
CD70 as a target in cancer immunotherapy: advances, challenges, and future directions
doi 10.3389/fonc.2025.1609840
- 1,461 views
ORIGINAL RESEARCH
Published on 23 Jul 2025
Deciphering the tumor ecosystem dynamics undergoing immunochemotherapy therapy across multiple cancer types unveils the immunosuppressive role of S100A4 in fibroblasts by promoting PD-L1 expression in tumor cells
doi 10.3389/fcell.2025.1613296
- 1,632 views
REVIEW
Published on 30 Jun 2025
Advances in immunotherapy for uveal melanoma: enhancing efficacy and overcoming resistance
doi 10.3389/fcell.2025.1619150
- 2,213 views
CASE REPORT
Published on 03 Jun 2025
MS-stable/TMB-high pleomorphic liposarcoma successfully treated with pembrolizumab: a case report
doi 10.3389/fonc.2025.1552411
- 1,465 views
REVIEW
Published on 30 May 2025
NK cell activity in the tumor microenvironment
doi 10.3389/fcell.2025.1609479
- 2,078 views
- 1 citation
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.